{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:10:26Z","timestamp":1793819426408,"version":"4.6.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13310-w","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T05:17:39Z","timestamp":1776748659000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and genotypic characteristics of antiviral-resistant herpes simplex virus 1 and 2 infections: a case series"],"prefix":"10.1186","volume":"26","author":[{"given":"Racha","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadhira","family":"Fidouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bunel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Bouscarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Issaurat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Joly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boutolleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"5","key":"13310_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2471\/BLT.19.237149","volume":"98","author":"C James","year":"2020","unstructured":"James C, Harfouche M, Welton NJ, Turner KM, Abu-Raddad LJ, Gottlieb SL, et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ. 2020, May, 1;98(5):315\u201329. https:\/\/doi.org\/10.2471\/BLT.19.237149 PubMed PMID: 32514197; PubMed Central PMCID: PMC7265941.","journal-title":"Bull World Health Organ"},{"issue":"206","key":"13310_CR2","doi-asserted-by":"publisher","first-page":"115322","DOI":"10.1016\/j.bcp.2022.115322","volume":"206","author":"HH Schalkwijk","year":"2022","unstructured":"Schalkwijk HH, Snoeck R, Andrei G. Acyclovir resistance in herpes simplex viruses: prevalence and therapeutic alternatives. Biochemical Pharmacol. 2022, Dec;206(206):115322. https:\/\/doi.org\/10.1016\/j.bcp.2022.115322.","journal-title":"Biochemical Pharmacol"},{"key":"13310_CR3","doi-asserted-by":"publisher","unstructured":"Crumpacker CS. Mechanism of action of foscarnet against viral polymerases. Am J Med. 1992, Feb, 14;92(2):S3\u20137. https:\/\/doi.org\/10.1016\/0002-9343(92)90329-A.","DOI":"10.1016\/0002-9343(92)90329-A"},{"issue":"1","key":"13310_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1386-6532(02)00263-9","volume":"26","author":"F Morfin","year":"2003","unstructured":"Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol. 2003, Jan, 1;26(1):29\u201337. https:\/\/doi.org\/10.1016\/S1386-6532(02)00263-9.","journal-title":"J Clin Virol"},{"issue":"5","key":"13310_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1684\/vir.2020.0864","volume":"24","author":"S Burrel","year":"2020","unstructured":"Burrel S, Topalis D, Boutolleau D. Herpes simplex virus resistance to antivirals. Virologie. 2020, Oct;24(5):325\u201342. https:\/\/doi.org\/10.1684\/vir.2020.0864.","journal-title":"Virologie"},{"issue":"11","key":"13310_CR6","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1128\/aac.00669-10","volume":"54","author":"S Burrel","year":"2010","unstructured":"Burrel S, Deback C, Agut H, Boutolleau D. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals. Antimicrob Agents Chemother. 2010, Nov;54(11):4833\u201342. https:\/\/doi.org\/10.1128\/aac.00669-10.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"13310_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.antiviral.2003.08.018","volume":"61","author":"D Chibo","year":"2004","unstructured":"Chibo D, Druce J, Sasadeusz J, Birch C. Molecular analysis of clinical isolates of acyclovir resistant herpes simplex virus. Antiviral Res. 2004, Feb;61(2):83\u201391. https:\/\/doi.org\/10.1016\/j.antiviral.2003.08.018 PubMed PMID: 14670581.","journal-title":"Antiviral Res"},{"key":"13310_CR8","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ajo.2022.01.010","volume":"238","author":"A Rousseau","year":"2022","unstructured":"Rousseau A, Pharm S, Gueudry J, Deback C, Haigh O, Schweitzer C, et al. Acyclovir-resistant herpes simplex virus 1 keratitis: a concerning and emerging clinical challenge. Am J Ophthalmol. 2022, Jun 238;238:110\u201319. https:\/\/doi.org\/10.1016\/j.ajo.2022.01.010 PubMed PMID: 35033543.","journal-title":"Am J Ophthalmol"},{"key":"13310_CR9","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.antiviral.2019.05.012","volume":"168","author":"T Labrunie","year":"2019","unstructured":"Labrunie T, Ducastelle S, Domenech C, Ader F, Morfin F, Frobert E. UL23, UL30, and UL5 characterization of HSV1 clinical strains isolated from hematology department patients. Antiviral Res. 2019, Aug 168;168:114\u201320. https:\/\/doi.org\/10.1016\/j.antiviral.2019.05.012 PubMed PMID: 31152759.","journal-title":"Antiviral Res"},{"issue":"4","key":"13310_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/jdv.20450","volume":"39","author":"R Patel","year":"2025","unstructured":"Patel R, Moran B, Clarke E, Geretti AM, Lautenschlager S, Green J, et al. 2024 European guidelines for the management of genital herpes. J Eur Acad Dermatol Venereol. 2025, 2025 Apr;39(4):742\u201358. https:\/\/doi.org\/10.1111\/jdv.20450.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"13310_CR11","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1093\/cid\/ciae638","volume":"81","author":"RF Chemaly","year":"2025","unstructured":"Chemaly RF, Shafat T, Wald A, Kotton CN, Papanicolaou G, Yong MK, et al. Refractory and resistant herpes simplex virus mucocutaneous infections in immunocompromised patients: literature review and proposed definitions for use in clinical trials. Clin Infect Dis. 2025, Jan, 29 ciae638;81(3):593\u2013601. https:\/\/doi.org\/10.1093\/cid\/ciae638.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"13310_CR12","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1086\/515626","volume":"178","author":"A Gaudreau","year":"1998","unstructured":"Gaudreau A, Hill E, Balfour HH Jr, Erice A, Boivin G. Phenotypic and genotypic characterization of acyclovir-resistant herpes simplex viruses from immunocompromised patients. The J Infect Dis. 1998, Aug, 1;178(2):297\u2013303. https:\/\/doi.org\/10.1086\/515626.","journal-title":"The J Infect Dis"},{"issue":"7","key":"13310_CR13","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1128\/jvi.75.7.3105-3110.2001","volume":"75","author":"J Bestman-Smith","year":"2001","unstructured":"Bestman-Smith J, Schmit I, Papadopoulou B, Boivin G. Highly reliable heterologous System for evaluating resistance of clinical herpes simplex virus isolates to nucleoside analogues. J Virol. 2001, Apr;75(7):3105\u201310. https:\/\/doi.org\/10.1128\/jvi.75.7.3105-3110.2001.","journal-title":"J Virol"},{"issue":"5","key":"13310_CR14","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1128\/aac.47.5.1707-1713.2003","volume":"47","author":"T Suzutani","year":"2003","unstructured":"Suzutani T, Ishioka K, De Clercq E, Ishibashi K, Kaneko H, Kira T, et al. Differential mutation patterns in thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 clones passaged in the presence of acyclovir or penciclovir. Antimicrob Agents Chemother. 2003, May;47(5):1707\u201313. https:\/\/doi.org\/10.1128\/aac.47.5.1707-1713.2003.","journal-title":"Antimicrob Agents Chemother"},{"key":"13310_CR15","doi-asserted-by":"publisher","unstructured":"van VM, Jing L, Osterhaus ADME, Sette A, Koelle DM, Verjans GMGM. Local CD4 and CD8 T-Cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia. PLoS Pathog. 2013, Aug, 15;9(8):e1003547. https:\/\/doi.org\/10.1371\/journal.ppat.1003547.","DOI":"10.1371\/journal.ppat.1003547"},{"issue":"5","key":"13310_CR16","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1093\/infdis\/jix605","volume":"217","author":"G Andrei","year":"2018","unstructured":"Andrei G, Gillemot S, Topalis D, Snoeck R. The anti\u2013human immunodeficiency virus drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus DNA polymerase. The J Infect Dis. 2018, Feb, 14;217(5):790\u2013801. https:\/\/doi.org\/10.1093\/infdis\/jix605.","journal-title":"The J Infect Dis"},{"issue":"1","key":"13310_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/jac\/dkv285","volume":"71","author":"A Sauerbrei","year":"2016","unstructured":"Sauerbrei A, Bohn-Wippert K, Kaspar M, Krumbholz A, Karrasch M, Zell R. Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2. The J Antimicrob Chemother. 2016, Jan;71(1):6\u201316. https:\/\/doi.org\/10.1093\/jac\/dkv285 PubMed PMID: 26433780.","journal-title":"The J Antimicrob Chemother"},{"issue":"2","key":"13310_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.antiviral.2013.09.012","volume":"100","author":"S Burrel","year":"2013","unstructured":"Burrel S, Aime C, Hermet L, Ait-Arkoub Z, Agut H, Boutolleau D. Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey. Antiviral Res. 2013, Nov;100(2):365\u201372. https:\/\/doi.org\/10.1016\/j.antiviral.2013.09.012 PubMed PMID: 24075863.","journal-title":"Antiviral Res"},{"key":"13310_CR19","doi-asserted-by":"publisher","unstructured":"Kuo JY, Yeh CS, Wang SM, Chen SH, Wang JR, Chen TY, et al. Acyclovir-resistant HSV-1 isolates among immunocompromised patients in southern Taiwan: low prevalence and novel mutations. J Med Virol. 2023;95(8):e28985. https:\/\/doi.org\/10.1002\/jmv.28985.","DOI":"10.1002\/jmv.28985"},{"issue":"6","key":"13310_CR20","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1128\/AAC.38.6.1246","volume":"38","author":"S Safrin","year":"1994","unstructured":"Safrin S, Elbeik T, Phan L, Robinson D, Rush J, Elbaggari A, et al. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 1994, Jun;38(6):1246\u201350. https:\/\/doi.org\/10.1128\/AAC.38.6.1246 PubMed PMID: 8092821; PubMed Central PMCID: PMC188193.","journal-title":"Antimicrob Agents Chemother"},{"issue":"167","key":"13310_CR21","doi-asserted-by":"publisher","first-page":"105554","DOI":"10.1016\/j.jcv.2023.105554","volume":"167","author":"HL Glasgow","year":"2023","unstructured":"Glasgow HL, Zhu H, Xie H, Kenkel EJ, Lee C, Huang ML, et al. Genotypic testing improves detection of antiviral resistance in human herpes simplex virus. J Clin Virol. 2023, Oct;167(167):105554. https:\/\/doi.org\/10.1016\/j.jcv.2023.105554.","journal-title":"J Clin Virol"},{"issue":"12","key":"13310_CR22","doi-asserted-by":"publisher","first-page":"6122","DOI":"10.1002\/jmv.28070","volume":"94","author":"L Khellaf","year":"2022","unstructured":"Khellaf L, Bouscarat F, Burrel S, Fidouh N, Hachon L, Bucau M, et al. Novel mutations in antiviral multiresistant HSV-2 genital lesion: a case report. J Med Virol. 2022, Dec;94(12):6122\u201326. https:\/\/doi.org\/10.1002\/jmv.28070 PubMed PMID: 35973907.","journal-title":"J Med Virol"},{"issue":"2","key":"13310_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.bbmt.2010.06.020","volume":"17","author":"JH Kim","year":"2011","unstructured":"Kim JH, Schaenman JM, Ho DY, Brown JMY. Treatment of acyclovir-resistant herpes simplex virus with continuous infusion of high-dose acyclovir in hematopoietic cell transplant patients. Biol Blood Marrow Transplant. 2011, Feb;17(2):259\u201364. https:\/\/doi.org\/10.1016\/j.bbmt.2010.06.020 PubMed PMID: 20615475.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"13310_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1399-3062.2010.00587.x","volume":"13","author":"I Engelmann","year":"2011","unstructured":"Engelmann I, Hesse N, Fegbeutel C, Str\u00fcber M, Wehrhane M, Gottlieb J, et al. Incidence and impact of herpes simplex and cytomegalovirus detection in the respiratory tract after lung transplantation. Transpl Infect Dis. 2011, Jun;13(3):259\u201365. https:\/\/doi.org\/10.1111\/j.1399-3062.2010.00587.x PubMed PMID: 21156011.","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"13310_CR25","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3390\/v15122326","volume":"15","author":"F Patrucco","year":"2023","unstructured":"Patrucco F, Curtoni A, Sidoti F, Zanotto E, Bondi A, Albera C, et al. Herpes virus infection in lung transplantation: diagnosis, treatment and prevention strategies. Viruses. 2023, Dec;15(12):2326. https:\/\/doi.org\/10.3390\/v15122326.","journal-title":"Viruses"},{"issue":"33","key":"13310_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijid.2015.02.002","volume":"33","author":"C Leeyaphan","year":"2015","unstructured":"Leeyaphan C, Surawan TM, Chirachanakul P, Prasertworonun N, Punyaratabandhu P, Omcharoen V, et al. Clinical characteristics of hypertrophic herpes simplex genitalis and treatment outcomes of imiquimod: a retrospective observational study. Int J Infect Dis. 2015, Apr;33(33):165\u201370. https:\/\/doi.org\/10.1016\/j.ijid.2015.02.002 PubMed PMID: 25660091.","journal-title":"Int J Infect Dis"},{"issue":"123","key":"13310_CR27","doi-asserted-by":"publisher","first-page":"104246","DOI":"10.1016\/j.jcv.2019.104246","volume":"123","author":"BM Sasso","year":"2020","unstructured":"Sasso BM, Florence MEB, Magalhaes RF, Velho PENF, de Souza EM, Cintra ML, et al. Herpes simplex virus mucocutaneous tumoural lesions \u2013 systematic review. J Clin Virol. 2020, Feb;123(123):104246. https:\/\/doi.org\/10.1016\/j.jcv.2019.104246.","journal-title":"J Clin Virol"},{"issue":"8","key":"13310_CR28","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1093\/jac\/dkac165","volume":"77","author":"A Serris","year":"2022","unstructured":"Serris A, Pouvaret A, Loiseau C, Abid H, Burrel S, Fourgeaud J, et al. Pritelivir for recurrent aciclovir-resistant herpes simplex virus 2 infections in immunocompromised patients. The J Antimicrob Chemother. 2022, Jul, 28;77(8):2303\u201305. https:\/\/doi.org\/10.1093\/jac\/dkac165 PubMed PMID: 35639560.","journal-title":"The J Antimicrob Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13310-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13310-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:27:42Z","timestamp":1780525662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13310-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13310"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13310-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Comit\u00e9 d\u2019Ethique de la Recherche (CER), Paris Nord (CER-2024\u2013284). All participants were informed about the study and give their oral non-opposition to collect their data with respect for anonymity.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"All authors give their approval for the publication of the article data in this journal. Oral non-opposition was obtained from living patients for the use of their clinical data. Due to the retrospective nature of the study, the ethics committee waived the requirement for written informed consent. For deceased patients, the ethics committee authorized data collection with strict respect for anonymity. All data were anonymized to ensure confidentiality. No personal data or identifiable images are included in this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1072"}}